BFSP2

Chr 3AD

beaded filament structural protein 2

Also known as: CP47, CP49, CTRCT12, LIFL-L, PHAKOSIN

More than 99% of the vertebrate ocular lens is comprised of terminally differentiated lens fiber cells. Two lens-specific intermediate filament-like proteins, the protein product of this gene (phakinin), and filensin, are expressed only after fiber cell differentiation has begun. Both proteins are found in a structurally unique cytoskeletal element that is referred to as the beaded filament (BF). Mutations in this gene have been associated with juvenile-onset, progressive cataracts and Dowling-Meara epidermolysis bullosa simplex. [provided by RefSeq, Jun 2009]

OMIMResearchGenerating clinical summary…
MultiplemechanismADLOEUF 1.041 OMIM phenotype
Clinical SummaryBFSP2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
4 unique Pathogenic / Likely Pathogenic· 90 VUS of 162 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
1.04LOEUF
pLI 0.000
Z-score 1.42
OE 0.67 (0.451.04)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint?
0.29Z-score
OE missense 0.95 (0.851.06)
239 obs / 252.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.67 (0.451.04)
00.351.4
Missense OE?0.95 (0.851.06)
00.61.4
Synonymous OE?0.88
01.21.6
LoF obs/exp: 15 / 22.3Missense obs/exp: 239 / 252.0Syn Z: 0.92
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveBFSP2-related cataractOTHERAR
definitiveBFSP2-related cataractOTHERAD

This gene — mechanism propensity

DN
0.89top 5%
GOF
0.84top 5%
LOF
0.2091th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

162 submitted variants in ClinVar

Classification Summary

Pathogenic4
VUS90
Likely Benign25
Benign33
Conflicting7
4
Pathogenic
90
VUS
25
Likely Benign
33
Benign
7
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
2
1
1
0
4
Likely Pathogenic
0
0
0
0
0
VUS
2
78
6
4
90
Likely Benign
0
4
15
6
25
Benign
0
4
21
8
33
Conflicting
7
Total4874318159

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

16 pathogenic / likely-pathogenic (of 19) ClinVar copy-number / structural variants overlap BFSP2 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

BFSP2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →